Federal contract award
75F40124F19001
SERVICES TO PROVIDE THE INVESTIGATION OF METABOLOMES OF PLASMA/SERUM AND/OR URINE TO DETERMINE THE UTILITY OF THIS PARADIGM FOR IDENTIFYING BIOMARKERS AND/OR METABOLOMIC SIGNATURES OF DRUG EXPOSURE AND RESPONSE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN41 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH |
| Parent award / vehicle | 75F40123D00031 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $151.7K |
| Current contract value | $151.7K |
| Potential contract value / ceiling | $151.7K |
| Start date | Aug 22, 2024 |
| Current end date | Sep 14, 2025 |
| Potential end date | Sep 14, 2025 |
| Latest award activity | Aug 22, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 22, 2024 | 0 | $151.7K | SERVICES TO PROVIDE THE INVESTIGATION OF METABOLOMES OF PLASMA/SERUM AND/OR URINE TO DETERMINE THE UTILITY OF THIS PARADIGM FOR IDENTIFYING BIOMARKERS AND/OR METABOLOMIC SIGNATURES OF DRUG EXPOSURE AND RESPONSE. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.